CDKN1A and Miyoshi myopathy: RT‐qPCR confirmed that the mRNA expression levels of CDKN1A and BCAT2 in three MM cells (RPMI 8226, WT‐U266, and LP‐1) were both significantly higher than the control HMy2.CIR cell line (p < 0.05).